News - Healthcare, Oncology

Filter

Current filters:

HealthcareOncology

Popular Filters

1 to 25 of 32 results

Physicians views on EGFR wild-type/untested NSCLC treatment

Physicians views on EGFR wild-type/untested NSCLC treatment

20-06-2014

According to surveyed US and European oncologists, improvement in efficacy endpoints are the most influential…

AstraZenecaBiotechnologyBristol-Myers SquibbEuropeHealthcareMarkets & MarketingMerck & ConivolumabOncologyOno PharmaceuticalpembrolizumabselumetinibUSA

EMA says that vials of falsified Herceptin have been identified

EMA says that vials of falsified Herceptin have been identified

16-04-2014

The European Medicines Agency says it has been informed that vials of Swiss drug major Roche’s blockbuster…

EuropeHealthcareHerceptinOncologyPharmaceuticalRegulationRoche

Latest Australian PBS Listings include medicines for children

Latest Australian PBS Listings include medicines for children

19-03-2014

Ten new medicines to treat a range of illnesses from rare forms of cancer to skin conditions will be…

Anti-Arthritics/RheumaticsAsia-PacificAustraliaDermatologicalsDiabetesGastro-intestinalsHealthcareOncologyPharmaceuticalPricing

Shifting payment dynamics for colorectal cancer and renal cell carcinoma treatment

Shifting payment dynamics for colorectal cancer and renal cell carcinoma treatment

06-03-2014

The increasing use of clinical pathway programs, accountable care organizations (ACOs) and bundled payments…

HealthcareOncologyPharmaceuticalPricing

Merck Serono’s Erbitux to be funded by CDF in England for mCRC

28-02-2014

The UK’s Cancer Drugs Fund (CDF) says that Erbitux (cetuximab) can be used in the first line setting…

ErbituxFinancialHealthcareMerck KGaAMerck SeronoNorthern EuropeOncologyPharmaceuticalUK

Australian patients benefit from PBS changes; cancer research

27-02-2014

New medicines for glaucoma, diabetes and advanced soft tissue sarcoma have been approved for listing…

Asia-PacificAustraliaDiabetesFinancialHealthcareKombiglyzeOncologyPharmaceuticalResearchTrajentaVotrient

UK’s NICE publishes new standards to improve care for children and young people with cancer

27-02-2014

All children and young people with cancer should have the opportunity to take part in relevant clinical…

HealthcareNorthern EuropeOncologyPharmaceuticalResearchUK

Lung cancer treatment takes another forward step in New Zealand

Lung cancer treatment takes another forward step in New Zealand

09-01-2014

Improvements in lung cancer treatment are set to continue with a decision for New Zealand’s Pharmaceutical…

Asia-PacificAstraZenecaFinancialHealthcareIressaOncologyPharmaceuticalRocheTarceva

New Brazilian law favors home treatment of cancer patients

20-11-2013

Starting next year, supplemental and private health insurance companies in Brazil will be required to…

FinancialHealthcareLegalOncologySouth America

UK’s Cancer Drugs Fund gets £400 million boost for life-saving drugs

UK’s Cancer Drugs Fund gets £400 million boost for life-saving drugs

30-09-2013

Thousands of cancer patients in England will get life-saving drugs thanks to an extra £400 million invested…

EuropeFinancialHealthcareOncologyPharmaceutical

Pressure mounts on UK government on future of the Cancer Drugs Fund

20-09-2013

A new survey in the UK has found that four in five adults want the National Health Service to offer levels…

EuropeFinancialHealthcareOncologyPharmaceutical

Developing cancer cures is top priority for Americans, survey shows

05-08-2013

A new survey commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA) shows 86%…

Cardio-vascularHealthcareNorth AmericaOncologyPharmaceuticalResearch

Outpatient chemotherapy administered in US hospitals increased by more than 150% since 2005

04-06-2013

A new study released by The Moran Company finds that, between 2005 and 2011, the relative number of chemotherapy…

FinancialHealthcareNorth AmericaOncologyPharmaceutical

Merck & Co's Gardasil and GSK's Cervarix to be available to developing countries via UNICEF tender

09-05-2013

A new record low price for human papillomavirus (HPV) vaccines will help ensure millions of girls in…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoOncologyPharmaceuticalPricingRest of the World

Australia to review way chemotherapy is funded

07-05-2013

Australia's Minister for Health Tanya Plibersek has announced a major review into the way chemotherapy…

Asia-PacificdocetaxelFinancialGenericsHealthcareOncologyPharmaceutical

More research needed on causes of leukemia, as growing lifespan of patients enables study, says GlobalData

18-04-2013

Chronic Myeloid Leukemia (CML) patients are now able to access more successful treatment, which has led…

BiotechnologyEuropeHealthcareNorth AmericaOncologyPharmaceuticalResearch

Prime market access levers for molecularly targeted oncology agents

20-03-2013

In the EU5 countries (France, Germany, Italy, Spain and the UK), interviewed payers and surveyed oncologists…

EuropeFinancialHealthcareOncologyPharmaceutical

HER2-positive breast cancer patients prefer faster subcutaneous administration of Herceptin to IV

15-03-2013

Results from the PrefHer (Patient Preference for Subcutaneous (SC) versus Intravenous (IV) Herceptin)…

EuropeFinancialHealthcareHerceptinOncologyPharmaceuticalRegulationRoche

Survey reveals 98.9% of US physicians experienced cancer drug shortages in last 12 months

15-11-2012

The Community Oncology Alliance (COA), a US non-profit organization, announced the results of a drug…

GenericsHealthcareNorth AmericaOncologyPharmaceuticalPricing

Economic burden of cancer in Europe exceeds 124 billion euros a year

01-10-2012

New studies that reveal for the first time the real economic and human costs of caring for cancer patients…

BiotechnologyEuropeFinancialHealthcareOncologyPharmaceutical

Scotland denies access to Roche skin cancer drug Zelboraf, but OKs Novartis' Gilenya

11-09-2012

Swiss drug major Roche (ROG SIX) says it is "extremely disappointed" that the Scottish Medicines Consortium…

EuropeGilenyaHealthcareNeurologicalNovartisOncologyPharmaceuticalPricingRegulationRocheZelboraf

First-line multiple myeloma patient share in Europe is variable by country

29-08-2012

Despite the considerable heterogeneity across different European countries, surveyed hematologist-oncologists…

AlkeranBiotechnologyCelgeneGlaxoSmithKlineHealthcareJohnson & JohnsonMarkets & MarketingOncologyPharmaceuticalThalomidVelcade

1 to 25 of 32 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top